Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole
{{output}}
The study aim was to identify early (within 14 days) and late changes (by 3 months) in breast cancer gene expression profiles associated with neoadjuvant therapy with letrozole. RNA from sequential tumour biopsies in 54 patients was analyzed on microarrays; ch... ...
